Diabetes drug trial - Alzheimer's

[Amity Island]

The study, of 204 people with Alzheimer’s disease in the United Kingdom, found that those taking the diabetes drug liraglutide – an earlier medication in Ozempic’s class, which are known as GLP-1 receptor agonists – had 18% slower cognitive decline over the course of a year compared with those taking a placebo.

https://edition.cnn.com/2024/07/30/health/liraglutide-alzheimers-trial/index.html

 

[christopher.lord]

Is that same drug there using for fat loss.